479 related articles for article (PubMed ID: 15333078)
1. Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence.
Osaka T; Yamazaki M; Yokoyama E; Ito A; Kodama I
J Cardiovasc Electrophysiol; 2004 Aug; 15(8):877-84. PubMed ID: 15333078
[TBL] [Abstract][Full Text] [Related]
2. Is atrial remodeling a viable target for prevention of atrial fibrillation recurrence?
Nattel S
J Cardiovasc Electrophysiol; 2004 Aug; 15(8):885-6. PubMed ID: 15333079
[No Abstract] [Full Text] [Related]
3. Effect of IKr blocker nifekalant on atrial action potential duration after successful internal cardioversion of chronic atrial fibrillation.
Kofune T; Watanabe I; Okubo K; Okumura Y; Masaki R; Shindo A; Saito S
Pacing Clin Electrophysiol; 2005 May; 28(5):391-6. PubMed ID: 15869670
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological effects of flecainide and sotalol in the human atrium during persistent atrial fibrillation.
Kirchhof P; Engelen M; Franz MR; Ribbing M; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Mar; 100(2):112-21. PubMed ID: 15696400
[TBL] [Abstract][Full Text] [Related]
5. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
[TBL] [Abstract][Full Text] [Related]
6. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation.
Raitt MH; Kusumoto W; Giraud G; McAnulty JH
J Cardiovasc Electrophysiol; 2004 May; 15(5):507-12. PubMed ID: 15149416
[TBL] [Abstract][Full Text] [Related]
7. Relations between monophasic action potential duration and refractoriness after cardioversion of persistent atrial fibrillation: results in wash-out and amiodarone-treated patients.
Pandozi C; Gentilucci G; Calò L; Castro A; Lamberti F; Loricchio ML; Santini L; Magris B; Bulava A; Peichl P; Santini M
Ital Heart J; 2003 Apr; 4(4):257-63. PubMed ID: 12784779
[TBL] [Abstract][Full Text] [Related]
8. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
Shan Z; Van Der Voort PH; Blaauw Y; Duytschaever M; Allessie MA
J Cardiovasc Electrophysiol; 2004 May; 15(5):572-80. PubMed ID: 15149428
[TBL] [Abstract][Full Text] [Related]
9. Action potential remodeling in the human right atrium with chronic lone atrial fibrillation.
Osaka T; Itoh A; Kodama I
Pacing Clin Electrophysiol; 2000 Jun; 23(6):960-5. PubMed ID: 10879379
[TBL] [Abstract][Full Text] [Related]
10. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
[TBL] [Abstract][Full Text] [Related]
11. Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
Kumar K; Nearing BD; Carvas M; Nascimento BC; Acar M; Belardinelli L; Verrier RL
J Cardiovasc Electrophysiol; 2009 Jul; 20(7):796-802. PubMed ID: 19298570
[TBL] [Abstract][Full Text] [Related]
12. Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion.
Tse HF; Lau CP; Ayers GM
Eur Heart J; 2000 Jul; 21(14):1167-76. PubMed ID: 10924300
[TBL] [Abstract][Full Text] [Related]
13. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
14. Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
Milberg P; Frommeyer G; Ghezelbash S; Rajamani S; Osada N; Razvan R; Belardinelli L; Breithardt G; Eckardt L
Europace; 2013 May; 15(5):761-9. PubMed ID: 23376977
[TBL] [Abstract][Full Text] [Related]
15. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
[TBL] [Abstract][Full Text] [Related]
16. Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation.
Miyauchi Y; Zhou S; Okuyama Y; Miyauchi M; Hayashi H; Hamabe A; Fishbein MC; Mandel WJ; Chen LS; Chen PS; Karagueuzian HS
Circulation; 2003 Jul; 108(3):360-6. PubMed ID: 12835207
[TBL] [Abstract][Full Text] [Related]
17. Effects of successful cardioversion of persistent atrial fibrillation on right ventricular refractoriness and repolarization.
Manios EG; Kallergis EM; Kanoupakis EM; Mavrakis HE; Mouloudi HK; Klapsinos NK; Vardas PE
Europace; 2005 Jan; 7(1):34-9. PubMed ID: 15670965
[TBL] [Abstract][Full Text] [Related]
18. Heart rate variability is a useful parameter for evaluation of anticholinergic effect associated with inducibility of atrial fibrillation.
Sugiura H; Chinushi M; Komura S; Hirono T; Aizawa Y
Pacing Clin Electrophysiol; 2005 Nov; 28(11):1208-14. PubMed ID: 16359288
[TBL] [Abstract][Full Text] [Related]
19. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter.
Franz MR; Karasik PL; Li C; Moubarak J; Chavez M
J Am Coll Cardiol; 1997 Dec; 30(7):1785-92. PubMed ID: 9385908
[TBL] [Abstract][Full Text] [Related]
20. Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man.
Kamalvand K; Tan K; Lloyd G; Gill J; Bucknall C; Sulke N
Eur Heart J; 1999 Jun; 20(12):888-95. PubMed ID: 10329094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
